Peptide record

TPDB42671

P7 Anticancer standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB42671
P7
Anticancer
Cancer-related peptides
ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF pep-lab
standard
No
A 11-aa standard natural anticancer peptide sequence curated from ACP740 _ACP240, AntiCP 2.0, CancerPPD 2.0, and other sources, with an available 3D structural model.
Sequence
PLLQATLGGGS
Physicochemical Analysis
C44H76N12O15
RNDCEHIKMFWYV
GL
1013.16
6.02
0
0
4
-0
-0.52
0.491
115.45
Mammalian: >20 hour Yeast: >20 hour E.coli: ?
0
0.00
3
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
1
Q
3
G
0
H
0
I
3
L
0
K
0
M
0
F
1
P
1
S
1
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 3 H: 0 I: 0 L: 3 K: 0 M: 0 F: 0 P: 1 S: 1 T: 1 W: 0 Y: 0 V: 0
Chemical Descriptors
11
C44H76N12O15
1013.16
6.02
-0
-0.52
0.491
Free
L
Linear
Free
Antiproliferative and Antiangiogenic
Evidence Records 1 records
Evidence 1 Activity

Activity

IC50
IC50= 1 µM
Anticancer
1 µM

Target

Skin Cancer
B16-F10
Skin

Assay & Model

WST-1 assay
48-h

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2012

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.